Acquired aplastic anemia and severe congenital neutropenia (SCN) are bone marrow (BM) failure syndromes of different origin, however, they share a common risk for secondary leukemic transformation. Here, we present a patient with severe aplastic anemia (SAA) evolving to secondary chronic neutrophilic leukemia (CNL; SAA-CNL). We show that SAA-CNL shares multiple somatic driver mutations in CSF3R, RUNX1, and EZH2/SUZ12 with cases of SCN that transformed to myelodysplastic syndrome or acute myeloid leukemia (AML). This molecular connection between SAA-CNL and SCN progressing to AML (SCN-AML) prompted us to perform a comparative transcriptome analysis on nonleukemic CD34high hematopoietic stem and progenitor cells, which showed transcriptional profiles that resemble indicative of interferon-driven proinflammatory responses. These findings provide further insights in the mechanisms underlying leukemic transformation in BM failure syndromes.,
Blood Advances
Department of Hematology

Schmied, L. (Laurent), Olofsen, P.A. (Patricia A.), Lundberg, P. (Pontus), Tzankov, A, Kleber, M, Halter, J.P, … Drexler, B. (Beatrice). (2020). Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes. Blood Advances, 4(21), 5540–5546. doi:10.1182/bloodadvances.2020001541